Patents by Inventor Emery Nyilas

Emery Nyilas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5061281
    Abstract: This invention relates to an implantable medical device capable of encouraging cellular growth and regeneration of function fabricated totally or in part from one or more bioresorbable polymers, as for example bioresorbable homopolymers derived from the polymerization of alpha-hydroxy carboxylic acids, where at least one of the polymers has an average molecular weight of from about 234,000 to about 320,000 as measured by gel permeation chromatography.
    Type: Grant
    Filed: December 17, 1986
    Date of Patent: October 29, 1991
    Assignee: Allied-Signal Inc.
    Inventors: Frank Mares, Reginald T. Tang, Tin-Ho Chiu, Theodore Largman, Emery Nyilas, deceased
  • Patent number: 4670286
    Abstract: A sterile shaped prosthetic device, suitable for insertion into a mammalian body, is at least partly composed of a bioresorbable material that is digestible by macrophages, its surface properties favor the attachment and adhesion of fibroblast cells capable of producing collagen for organized connective tissues, and the material itself or its degradation products can induce in vivo the formation of new capillary vessels (termed a "vasotropic" effect herein). Preferred prosthetic devices have through passages, the interspatial dimensions which are sufficient to permit several layers of mammalian cells to form within each passage. The invading fibroblast cells commence formation of collagen leading to connective tissue while macrophages and extracellular enzymes degrade the material, and newly formed capillary vessels penetrate the prosthesis and provide blood containing oxygen and nutrients which further the formation of organized tissue around as well as within the prosthetic device.
    Type: Grant
    Filed: December 26, 1985
    Date of Patent: June 2, 1987
    Assignee: Allied Corporation
    Inventors: Emery Nyilas, Tin-Ho Chiu
  • Patent number: 4594407
    Abstract: A sterile shaped prosthetic device, suitable for insertion into a mammalian body, is at least partly composed of a bioresorbable material that is digestible by macrophages, its surface properties favor the attachment and adhesion of fibroblast cells capable of producing collagen for organized connective tissues, and the material itself or its degradation products can induce in vivo the formation of new capillary vessels (termed a "vasotropic" effect herein). Preferred prosthetic devices have through passages, the interspatial dimensions which are sufficient to permit several layers of mammalian cells to form within each passage. The invading fibroblast cells commence formation of collagen leading to connective tissue while macrophages and extracellular enzymes degrade the material, and newly formed capillary vessels penetrate the prosthesis and provide blood containing oxygen and nutrients which further the formation of organized tissue around as well as within the prosthetic device.
    Type: Grant
    Filed: September 20, 1983
    Date of Patent: June 10, 1986
    Assignee: Allied Corporation
    Inventors: Emery Nyilas, Tin-Ho Chiu
  • Patent number: 4481353
    Abstract: Bioresorbable polyesters composed of, in one aspect, the Krebs Cycle dicarboxylic acid or isomer or anhydride thereof, chosen for the group consisting of succinic acid, fumaric acid, oxaloacetic acid, L-malic acid, and D-malic acid, a diol having 2, 4, 6, or 8 carbon atoms, and an alpha-hydroxy carboxylic acid chosen from the group consisting of glycolic acid L-lactic acid and D-lactic acid.
    Type: Grant
    Filed: October 7, 1983
    Date of Patent: November 6, 1984
    Assignee: The Children's Medical Center Corporation
    Inventors: Emery Nyilas, Tin-Ho Chiu